Profil
Thomas D.
Willis was the founder of ParAllele BioScience, Inc., founded in 2001, where the title held was Chief Scientific Officer from 2001 to 2013.
Dr. Willis is the founder of Sequenta, Inc., founded in 2007, holding the title of Chief Executive Officer.
Current jobs include Chief Executive Officer & Director at Arima Genomics, Inc. starting in 2025, and Venture Partner at IIF Management Co. LLC since 2017.
Former jobs include Director at Boreal Genomics, Inc., Director at SpinX Technologies SA, Vice President-DNA Product Marketing at Affymetrix, Inc. in 2007, and Principal at Stanford Genome Technology Center from 1996 to 2013.
Education includes graduate and doctorate degrees from Stanford University and an undergraduate degree from Yale University.
Aktive Positionen von Thomas Willis
| Unternehmen | Position | Beginn |
|---|---|---|
Sequenta, Inc.
Sequenta, Inc. BiotechnologyHealth Technology Operates as a biotech company which discovers and develops clinical diagnostics based on immune system status | Vorstandsvorsitzender | 18.08.2010 |
IIF Management Co. LLC
IIF Management Co. LLC Investment ManagersFinance Illumina Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of life science tools, diagnostics, therapeutics, digital health and sustainability sectors. It provides financing for early stage capital requirements. | Private Equity Investor | 01.01.2017 |
Arima Genomics Inc.
Arima Genomics Inc. BiotechnologyHealth Technology Develops clinical tests and technology platforms that uncover cancer-driving alterations | Vorstandsvorsitzender | 17.06.2025 |
Ehemalige bekannte Positionen von Thomas Willis
| Unternehmen | Position | Ende |
|---|---|---|
SpinX Technologies SA
SpinX Technologies SA Medical SpecialtiesHealth Technology Develops and manufactures laboratory equipment | Direktor/Vorstandsmitglied | 12.08.2010 |
| AFFYMETRIX, INC. | Vertrieb & Marketing | 01.01.2007 |
Boreal Genomics, Inc.
Boreal Genomics, Inc. Medical SpecialtiesHealth Technology Develops and markets DNA and RNA purification, enrichment, and detection equipment and tools | Vorsitzender | - |
Stanford Genome Technology Center | Corporate Officer/Principal | - |
ParAllele BioScience, Inc.
ParAllele BioScience, Inc. Miscellaneous Commercial ServicesCommercial Services Develops biochemical processes to analyze variations in the human genome | Vorstandsvorsitzender | - |
Ausbildung von Thomas Willis
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Affymetrix, Inc.
Affymetrix, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells products and services for genetic analysis | Health Technology |
ParAllele BioScience, Inc.
ParAllele BioScience, Inc. Miscellaneous Commercial ServicesCommercial Services Develops biochemical processes to analyze variations in the human genome | Commercial Services |
Sequenta, Inc.
Sequenta, Inc. BiotechnologyHealth Technology Operates as a biotech company which discovers and develops clinical diagnostics based on immune system status | Health Technology |
Boreal Genomics, Inc.
Boreal Genomics, Inc. Medical SpecialtiesHealth Technology Develops and markets DNA and RNA purification, enrichment, and detection equipment and tools | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SpinX Technologies SA
SpinX Technologies SA Medical SpecialtiesHealth Technology Develops and manufactures laboratory equipment | Health Technology |
Stanford Genome Technology Center | |
IIF Management Co. LLC
IIF Management Co. LLC Investment ManagersFinance Illumina Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of life science tools, diagnostics, therapeutics, digital health and sustainability sectors. It provides financing for early stage capital requirements. | Finance |
Arima Genomics Inc.
Arima Genomics Inc. BiotechnologyHealth Technology Develops clinical tests and technology platforms that uncover cancer-driving alterations | Health Technology |
















